Filter
1452
Filtered Results: 1452
Text search:
pharmacists
Featured
Recommendations
117
New Publications
429
Language
Document type
No document type
764
Guidelines
247
Studies & Reports
228
Manuals
82
Strategic & Response Plan
44
Training Material
27
Fact sheets
24
Situation Updates
12
Brochures
10
Resource Platforms
8
Online Courses
3
Infographics
2
Dashboards/Maps
1
Countries / Regions
India
80
Kenya
63
South Africa
55
Ethiopia
46
Nigeria
42
Global
38
Liberia
35
Ghana
33
Uganda
31
Sierra Leone
30
Rwanda
30
Zambia
26
Namibia
25
Burkina Faso
24
Tanzania
24
Bangladesh
22
Senegal
21
Nepal
21
Western and Central Europe
21
Congo, Democratic Republic of
19
Malawi
19
Myanmar / Burma
19
Africa
18
Benin
16
Syria
15
Haiti
14
Zimbabwe
12
Ukraine
11
Botswana
11
Indonesia
9
Lesotho
9
West and Central Africa
9
Cameroon
8
Eswatini/ Swaziland
8
East and Southern Africa
8
South–East Asia Region
8
Eastern Europe
8
Guinea
7
Philippines
7
Cambodia
7
Lebanon
6
Madagascar
6
Latin America and the Carribbean
6
Eastern Europe and Central Asia
6
Pakistan
5
Jordan
5
Germany
5
Middle East and North Africa
5
Asia
5
Iraq
4
Mozambique
4
Sudan
4
Morocco
3
Saudi Arabia
3
Togo
3
Somalia
3
South Sudan
3
Thailand
3
Central African Republic
3
Libya
3
Chile
3
Fiji
3
Bhutan
3
Albania
3
Russia
3
Georgia
3
United Kingdom
3
Mali
2
USA
2
Afghanistan
2
Turkey
2
Egypt
2
Argentina
2
Serbia
2
Colombia
2
Bolivia
2
Laos
2
Tajikistan
2
Qatar
2
Iran
2
North America
2
France
2
Tunisia
2
Guinea-Bissau
1
Chad
1
Gambia
1
China
1
Malaysia
1
Papua New Guinea
1
Peru
1
North Macedonia
1
Switzerland
1
Hungary
1
Burundi
1
Ecuador
1
Greece
1
Angola
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Solomon Islands
1
Venezuela
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Moldova
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
728
Clinical Guidelines
90
Public Health
65
Women & Child Health
50
Key Resources
38
Capacity Building
28
Pharmacy & Technologies
13
Annual Report MEDBOX
2
Toolboxes
AMR
160
Pharmacy
130
HIV
69
TB
69
Caregiver
56
Mental Health
55
COVID-19
50
NCDs
43
Conflict
24
Refugee
24
Ebola
20
Rapid Response
18
NTDs
16
Disability
9
Planetary Health
9
Social Ethics
5
Cholera
4
Global Health Education
4
Polio
3
Zika
3
Natural Hazards
2
Specific Hazards
2
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
The purpose of this workbook is to assist ministries of health, health managers and practitioners in engaging with the private sector on delivery of quality maternal, newborn and child health (MNCH) services in lower- and middle-income countries. Private health care is one of the fastest growing seg...
The document provides the NICE Quality Standard for managing Type 2 diabetes in adults (QS209). It outlines evidence-based recommendations for preventing Type 2 diabetes, structured education, continuous glucose monitoring (CGM), medication such as SGLT2 inhibitors, and regular care processes to mon...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
The Government of Malawi is committed to improving health and livelihoods in Malawi through community health – the
provision of basic health services in rural and urban communities with the participation of people who live there.
Historically, Community Health has significantly contributed to im...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial globa...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
